gabapentin has been researched along with Symptom Cluster in 41 studies
Gabapentin: A cyclohexane-gamma-aminobutyric acid derivative that is used for the treatment of PARTIAL SEIZURES; NEURALGIA; and RESTLESS LEGS SYNDROME.
gabapentin : A gamma-amino acid that is cyclohexane substituted at position 1 by aminomethyl and carboxymethyl groups. Used for treatment of neuropathic pain and restless legs syndrome.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A double-blind, randomised, placebo-controlled 8-week study was conducted to evaluate the efficacy and safety of gabapentin in the treatment of neuropathic pain, using doses up to 2400 mg/day." | 9.10 | Gabapentin in neuropathic pain syndromes: a randomised, double-blind, placebo-controlled trial. ( Serpell, MG, 2002) |
| "Gabapentin was initially developed as an antiepileptic drug but was later discovered to be an effective treatment of neuropathic pain." | 8.86 | Gabapentin for the treatment of cancer-related pain syndromes. ( Bar Ad, V, 2010) |
| " Gabapentin was effective in the treatment of painful diabetic neuropathy, postherpetic neuralgia, and other neuropathic pain syndromes." | 8.82 | Gabapentin dosing for neuropathic pain: evidence from randomized, placebo-controlled clinical trials. ( Backonja, M; Glanzman, RL, 2003) |
| "Although gabapentin was originally developed for treating partial seizures, it has been used mainly to treat various peripheral neuropathic pain conditions; however, there is very limited experience with gabapentin for the treatment of pain conditions of the central nervous system like central post-stroke pain syndrome." | 7.71 | Central post-stroke pain syndrome: yet another use for gabapentin? ( Chen, B; DeLisa, JA; Foye, PM; Nadler, SF; Stitik, TP, 2002) |
| "Gabapentin was administered orally in gradually increasing doses up to a maximum of 2,400 mg/day." | 6.69 | Effects of gabapentin on the different components of peripheral and central neuropathic pain syndromes: a pilot study. ( Attal, N; Bouhassira, D; Brasseur, L; Chauvin, M; Parker, F, 1998) |
| "Gabapentin is a novel anticonvulsant that may have a unique effect on voltage-dependent Ca2+ channel currents at postsynaptic dorsal horn neurons." | 6.41 | Gabapentin use in neuropathic pain syndromes. ( Nicholson, B, 2000) |
| "Oral gabapentin was prescribed simultaneously for 4 months, relieving her skin pruritus and suggesting that early treatment with pimecrolimus, acitretin and gabapentin for SAM-DSP syndrome is effective." | 5.51 | Severe dermatitis, multiple allergies and metabolic wasting (SAM) syndrome caused by de novo mutation in the DSP gene misdiagnosed as generalized pustular psoriasis and treatment of acitretin with gabapentin. ( Li, C; Li, M; Liang, J; Ni, C; Yao, Z; Yu, H; Zhang, Z, 2019) |
| "Gabapentin (Neurontin) was then started with improvement at 1800 mg per day." | 5.31 | SUNCT syndrome responsive to gabapentin (Neurontin). ( Graff-Radford, SB, 2000) |
| "Cramps were mainly nocturnal and also precipitated by walking; a previous treatment with carbamazepine did not improve the symptoms." | 5.30 | A case of myokymia-cramp syndrome successfully treated with gabapentin. ( Cardinali, P; Parisi, L; Pierelli, F; Rossi, P; Serrao, M; Tramutoli, R, 1998) |
| "A double-blind, randomised, placebo-controlled 8-week study was conducted to evaluate the efficacy and safety of gabapentin in the treatment of neuropathic pain, using doses up to 2400 mg/day." | 5.10 | Gabapentin in neuropathic pain syndromes: a randomised, double-blind, placebo-controlled trial. ( Serpell, MG, 2002) |
| "Gabapentin was initially developed as an antiepileptic drug but was later discovered to be an effective treatment of neuropathic pain." | 4.86 | Gabapentin for the treatment of cancer-related pain syndromes. ( Bar Ad, V, 2010) |
| " Gabapentin was effective in the treatment of painful diabetic neuropathy, postherpetic neuralgia, and other neuropathic pain syndromes." | 4.82 | Gabapentin dosing for neuropathic pain: evidence from randomized, placebo-controlled clinical trials. ( Backonja, M; Glanzman, RL, 2003) |
| "We report a case of red scrotal syndrome responding to oral gabapentin, a neuropathic mediator that is commonly used in the treatment of primary erythromelalgia." | 3.74 | Case reports: red scrotal syndrome: a localized phenotypical expression of erythromelalgia. ( English, JC; Prevost, N, 2007) |
| "Aromatic anticonvulsant agents such as carbamazepine and phenytoin can induce anticonvulsant hypersensitivity syndrome (AHS) at a frequency of 1 in 10,000 to 1 in 1,000 treated patients." | 3.73 | Anticonvulsant hypersensitivity syndrome: cross-reactivity with tricyclic antidepressant agents. ( Bröcker, EB; Pfeuffer, P; Raith, P; Seitz, CS; Trautmann, A, 2006) |
| "Case report on a patient with SUNCT-syndrome (short lasting, unilateral neuralgiform headache attacks with conjunctival injection, sweating, and rhinorrhoea) who was successfully treated with gabapentin." | 3.72 | [Case report on a patient with SUNCT-syndrome]. ( Brinkschmidt, T; Jensen, U; Neumeier, S, 2003) |
| "Although gabapentin was originally developed for treating partial seizures, it has been used mainly to treat various peripheral neuropathic pain conditions; however, there is very limited experience with gabapentin for the treatment of pain conditions of the central nervous system like central post-stroke pain syndrome." | 3.71 | Central post-stroke pain syndrome: yet another use for gabapentin? ( Chen, B; DeLisa, JA; Foye, PM; Nadler, SF; Stitik, TP, 2002) |
| "Patients with diabetic polyneuropathy were examined to study their biological age, rate of aging and pain syndrome." | 2.76 | [Biological age and the pain syndrome at diabetic polyneuropathy]. ( Emel'ianov, VV; Galkin, VV; Nesterova, MV, 2011) |
| "Gabapentin was administered orally in gradually increasing doses up to a maximum of 2,400 mg/day." | 2.69 | Effects of gabapentin on the different components of peripheral and central neuropathic pain syndromes: a pilot study. ( Attal, N; Bouhassira, D; Brasseur, L; Chauvin, M; Parker, F, 1998) |
| "Dizziness is not a unique clinical picture, but rather is the unspecific symptom of numerous diseases." | 2.44 | [Frequently occurring forms of dizziness and their treatment]. ( Thömke, F, 2007) |
| "Gabapentin is a novel anticonvulsant that may have a unique effect on voltage-dependent Ca2+ channel currents at postsynaptic dorsal horn neurons." | 2.41 | Gabapentin use in neuropathic pain syndromes. ( Nicholson, B, 2000) |
| "Oral gabapentin was prescribed simultaneously for 4 months, relieving her skin pruritus and suggesting that early treatment with pimecrolimus, acitretin and gabapentin for SAM-DSP syndrome is effective." | 1.51 | Severe dermatitis, multiple allergies and metabolic wasting (SAM) syndrome caused by de novo mutation in the DSP gene misdiagnosed as generalized pustular psoriasis and treatment of acitretin with gabapentin. ( Li, C; Li, M; Liang, J; Ni, C; Yao, Z; Yu, H; Zhang, Z, 2019) |
| "Persistent and treatment-resistant neuropathic pain may be a prominent feature in hantavirus-associated peripheral neuropathy." | 1.46 | A neuropathic pain syndrome associated with hantavirus infection. ( Anderson, D; Beecher, G; Bridgland, L; Power, C; Zochodne, DW, 2017) |
| "Neuropathic and/or neuralgic facial pain occurred in 50% (n = 7)." | 1.35 | The trigeminal trophic syndrome: an unusual cause of face pain, dysaesthesias, anaesthesia and skin/soft tissue lesions. ( Garza, I, 2008) |
| "Pelvic pain was detected 5 days after antigen instillation and was sustained beyond 30 days, indicating the development of chronic pain." | 1.35 | Experimental autoimmune prostatitis induces chronic pelvic pain. ( Rudick, CN; Schaeffer, AJ; Thumbikat, P, 2008) |
| "Paroxysmal autonomic instability with dystonia, an under-recognized and poorly understood phenomenon of episodic central dysautonomia is associated with various cerebral insults." | 1.34 | Paroxysmal autonomic instability with dystonia. ( Lim, CC; Srinivasan, S; Thirugnanam, U, 2007) |
| "This syndrome is accompanied by fever, rash, lymphadenopathy, eosinophilia and affects parenchymal organs." | 1.32 | [Anticonvulsant hypersensitivity syndrome]. ( Papp, Z; Török, L, 2004) |
| "Gabapentin (Neurontin) was then started with improvement at 1800 mg per day." | 1.31 | SUNCT syndrome responsive to gabapentin (Neurontin). ( Graff-Radford, SB, 2000) |
| "Cramps were mainly nocturnal and also precipitated by walking; a previous treatment with carbamazepine did not improve the symptoms." | 1.30 | A case of myokymia-cramp syndrome successfully treated with gabapentin. ( Cardinali, P; Parisi, L; Pierelli, F; Rossi, P; Serrao, M; Tramutoli, R, 1998) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (7.32) | 18.2507 |
| 2000's | 26 (63.41) | 29.6817 |
| 2010's | 11 (26.83) | 24.3611 |
| 2020's | 1 (2.44) | 2.80 |
| Authors | Studies |
|---|---|
| Mizes, A | 1 |
| Bunimovich, O | 1 |
| Bunimovich, YL | 1 |
| Bögli, SY | 1 |
| Afthinos, M | 1 |
| Huang, MY | 1 |
| Anderson, D | 1 |
| Beecher, G | 1 |
| Power, C | 1 |
| Bridgland, L | 1 |
| Zochodne, DW | 1 |
| Arellano, AL | 1 |
| Martin-Subero, M | 1 |
| Monerris, M | 1 |
| LLerena, A | 1 |
| Farré, M | 1 |
| Montané, E | 1 |
| Liang, J | 1 |
| Li, C | 1 |
| Zhang, Z | 1 |
| Ni, C | 1 |
| Yu, H | 1 |
| Li, M | 1 |
| Yao, Z | 1 |
| Rashiq, S | 1 |
| Dick, BD | 1 |
| Roldan, CJ | 1 |
| Lesnick, JS | 1 |
| Nair, AG | 2 |
| Shah, BR | 1 |
| Gandhi, RA | 1 |
| Alrawashdeh, O | 1 |
| Garza, I | 1 |
| Bar Ad, V | 1 |
| Lantos, PM | 1 |
| Galkin, VV | 1 |
| Nesterova, MV | 1 |
| Emel'ianov, VV | 1 |
| Porta-Etessam, J | 2 |
| Benito-Leon, J | 1 |
| Martinez-Salio, A | 2 |
| Berbel, A | 1 |
| Hunt, CH | 1 |
| Dodick, DW | 1 |
| Bosch, EP | 1 |
| Chen, B | 1 |
| Stitik, TP | 1 |
| Foye, PM | 1 |
| Nadler, SF | 1 |
| DeLisa, JA | 1 |
| Serpell, MG | 1 |
| Guéguen, A | 1 |
| Guy, C | 1 |
| Cartry, O | 1 |
| Bouchou, K | 1 |
| Gouilloud, S | 1 |
| Cathébras, P | 1 |
| Nicolas, X | 1 |
| Vaillant, PY | 1 |
| Bellard, S | 1 |
| Backonja, M | 1 |
| Glanzman, RL | 1 |
| Neumeier, S | 1 |
| Brinkschmidt, T | 1 |
| Jensen, U | 1 |
| Oefelein, MG | 1 |
| Bayazit, Y | 1 |
| Villarejo, A | 1 |
| Camacho, A | 1 |
| González De La Aleja, J | 1 |
| Penas, M | 1 |
| Papp, Z | 1 |
| Török, L | 1 |
| Finucane, TE | 1 |
| Seitz, CS | 1 |
| Pfeuffer, P | 1 |
| Raith, P | 1 |
| Bröcker, EB | 1 |
| Trautmann, A | 1 |
| Barsukov, IN | 1 |
| Kashin, AV | 1 |
| Kostiuk, GP | 1 |
| Srinivasan, S | 1 |
| Lim, CC | 1 |
| Thirugnanam, U | 1 |
| Thömke, F | 1 |
| Spiller, J | 1 |
| Prevost, N | 1 |
| English, JC | 1 |
| Aizawa, H | 1 |
| Rudick, CN | 1 |
| Schaeffer, AJ | 1 |
| Thumbikat, P | 1 |
| Baillieux, H | 1 |
| Verslegers, W | 1 |
| Paquier, P | 1 |
| De Deyn, PP | 1 |
| Mariën, P | 1 |
| Vossler, DG | 1 |
| Attal, N | 1 |
| Brasseur, L | 1 |
| Parker, F | 1 |
| Chauvin, M | 1 |
| Bouhassira, D | 1 |
| Serrao, M | 1 |
| Cardinali, P | 1 |
| Rossi, P | 1 |
| Parisi, L | 1 |
| Tramutoli, R | 1 |
| Pierelli, F | 1 |
| Nicholson, B | 1 |
| Graff-Radford, SB | 1 |
| Derk, CT | 1 |
| Cynwyd, B | 1 |
| Paulig, M | 1 |
| Mentrup, H | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Double Blind Trial Investigating the Role of Sulfasalazine in Decreasing Opioids Requirements in Breast Cancer Patients[NCT03847311] | Phase 2 | 40 participants (Anticipated) | Interventional | 2021-05-03 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
5 reviews available for gabapentin and Symptom Cluster
| Article | Year |
|---|---|
Post-surgical pain syndromes: a review for the non-pain specialist.
Topics: Age Factors; Amines; Analgesics; Anesthesia; Anesthetics; Anesthetics, Local; Animals; Chronic Pain; | 2014 |
Gabapentin for the treatment of cancer-related pain syndromes.
Topics: Amines; Analgesics; Chronic Disease; Cyclohexanecarboxylic Acids; Gabapentin; gamma-Aminobutyric Aci | 2010 |
Gabapentin dosing for neuropathic pain: evidence from randomized, placebo-controlled clinical trials.
Topics: Acetates; Amines; Analgesics; Analgesics, Opioid; Anti-Inflammatory Agents, Non-Steroidal; Anticonvu | 2003 |
[Frequently occurring forms of dizziness and their treatment].
Topics: Amines; Anticonvulsants; Betahistine; Carbamazepine; Cyclohexanecarboxylic Acids; Diagnosis, Differe | 2007 |
Gabapentin use in neuropathic pain syndromes.
Topics: Acetates; Amines; Analgesics; Cyclohexanecarboxylic Acids; Gabapentin; gamma-Aminobutyric Acid; Huma | 2000 |
5 trials available for gabapentin and Symptom Cluster
| Article | Year |
|---|---|
[Biological age and the pain syndrome at diabetic polyneuropathy].
Topics: Adult; Aging; Amines; Calcium Channel Blockers; Cyclohexanecarboxylic Acids; Diabetic Neuropathies; | 2011 |
Gabapentin in neuropathic pain syndromes: a randomised, double-blind, placebo-controlled trial.
Topics: Acetates; Adult; Aged; Aged, 80 and over; Amines; Analysis of Variance; Chi-Square Distribution; Cyc | 2002 |
Gabapentin for painful legs and moving toes syndrome.
Topics: Acetates; Aged; Amines; Cyclohexanecarboxylic Acids; Electromyography; Excitatory Amino Acid Antagon | 2004 |
[The tebantin use in the complex therapy of pain syndrome during the mixed forms of alcoholic polyneuropathy].
Topics: Alcoholic Neuropathy; Amines; Analgesics; Cyclohexanecarboxylic Acids; Drug Therapy, Combination; Fe | 2006 |
Effects of gabapentin on the different components of peripheral and central neuropathic pain syndromes: a pilot study.
Topics: Acetates; Amines; Analgesics; Anticonvulsants; Central Nervous System Diseases; Cyclohexanecarboxyli | 1998 |
31 other studies available for gabapentin and Symptom Cluster
| Article | Year |
|---|---|
Combined carvedilol and gabapentin treatment induces a rapid response in red scrotum syndrome.
Topics: Carvedilol; Drug Combinations; Erythema; Gabapentin; Genital Diseases, Male; Humans; Male; Middle Ag | 2021 |
Effect of Gabapentin/Memantine on the Infantile Nystagmus Syndrome in the Zebrafish Model: Implications for the Therapy of Ocular Motor Diseases.
Topics: Amines; Animals; Calcium Channel Blockers; Cyclohexanecarboxylic Acids; Disease Models, Animal; Exci | 2017 |
A neuropathic pain syndrome associated with hantavirus infection.
Topics: Adult; Amines; Analgesics; Anti-Inflammatory Agents, Non-Steroidal; Cyclohexanecarboxylic Acids; Gab | 2017 |
Multiple adverse drug reactions and genetic polymorphism testing: A case report with negative result.
Topics: Amines; Amitriptyline; Analgesics; Cyclohexanecarboxylic Acids; Drug Hypersensitivity; Female; Gabap | 2017 |
Severe dermatitis, multiple allergies and metabolic wasting (SAM) syndrome caused by de novo mutation in the DSP gene misdiagnosed as generalized pustular psoriasis and treatment of acitretin with gabapentin.
Topics: Acitretin; Administration, Cutaneous; Administration, Oral; Child, Preschool; Dermatitis, Exfoliativ | 2019 |
Phantom organ pain syndrome, a ghostly visitor to the ED.
Topics: Adult; Amines; Analgesics; Cyclohexanecarboxylic Acids; Emergency Service, Hospital; Gabapentin; gam | 2014 |
Seeing the unseen: Charles Bonnet syndrome revisited.
Topics: Aged; Amines; Awareness; Cyclohexanecarboxylic Acids; Female; Gabapentin; gamma-Aminobutyric Acid; H | 2015 |
Painless legs and moving toes syndrome associated with a sacral Tarlov cyst: a case report.
Topics: Amines; Antiparkinson Agents; Cyclohexanecarboxylic Acids; Dyskinesias; Female; Gabapentin; gamma-Am | 2016 |
The trigeminal trophic syndrome: an unusual cause of face pain, dysaesthesias, anaesthesia and skin/soft tissue lesions.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amines; Child; Cyclohexanecarboxylic Acids; Erythema; Fa | 2008 |
Chronic Lyme disease: the controversies and the science.
Topics: Amines; Analgesics; Anti-Bacterial Agents; Arthritis, Rheumatoid; Borrelia burgdorferi; Chronic Dise | 2011 |
Gabapentin in the treatment of SUNCT syndrome.
Topics: Acetates; Amines; Analgesics; Conjunctiva; Cyclohexanecarboxylic Acids; Female; Gabapentin; gamma-Am | 2002 |
SUNCT responsive to gabapentin.
Topics: Acetates; Adult; Amines; Analgesics; Conjunctiva; Cyclohexanecarboxylic Acids; Female; Gabapentin; g | 2002 |
Central post-stroke pain syndrome: yet another use for gabapentin?
Topics: Acetates; Activities of Daily Living; Administration, Oral; Amines; Analgesics; Cyclohexanecarboxyli | 2002 |
[Edematous syndrome and alithiasic cholecystitis induced by gabapentin].
Topics: Acetates; Adult; Amines; Anticonvulsants; Cholecystitis; Cyclohexanecarboxylic Acids; Edema; Epileps | 2002 |
[Recognizing the "neck-tongue" syndrome].
Topics: Acetates; Amines; Analgesics; Analgesics, Non-Narcotic; Arthritis; Cervical Vertebrae; Cyclohexaneca | 2003 |
[Case report on a patient with SUNCT-syndrome].
Topics: Acetates; Amines; Analgesics; Cyclohexanecarboxylic Acids; Female; Functional Laterality; Gabapentin | 2003 |
Chronic pain syndrome after laparoscopic radical nephrectomy.
Topics: Acetates; Aged; Amines; Analgesics; Analgesics, Opioid; Carcinoma, Renal Cell; Carcinoma, Transition | 2003 |
[Anticonvulsant hypersensitivity syndrome].
Topics: Acetates; Amines; Anticonvulsants; Carbamazepine; Cyclohexanecarboxylic Acids; Drug Eruptions; Drug | 2004 |
Neurontin for Charles Bonnet Syndrome.
Topics: Amines; Central Nervous System Agents; Cyclohexanecarboxylic Acids; Gabapentin; gamma-Aminobutyric A | 2006 |
Anticonvulsant hypersensitivity syndrome: cross-reactivity with tricyclic antidepressant agents.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amines; Amitriptyline; Anticonvulsants; Antidepressive A | 2006 |
Paroxysmal autonomic instability with dystonia.
Topics: Adult; Amines; Autonomic Nervous System Diseases; Benzodiazepines; Brain Injuries; Cyclohexanecarbox | 2007 |
Acupuncture, ketamine and piriformis syndrome--a case report from palliative care.
Topics: Acupuncture Therapy; Amines; Analgesics; Combined Modality Therapy; Cyclohexanecarboxylic Acids; Gab | 2007 |
Case reports: red scrotal syndrome: a localized phenotypical expression of erythromelalgia.
Topics: Administration, Oral; Amines; Analgesics; Cyclohexanecarboxylic Acids; Erythromelalgia; Gabapentin; | 2007 |
Gabapentin for painful legs and moving toes syndrome.
Topics: Aged; Amines; Analgesics; Cyclohexanecarboxylic Acids; Female; Gabapentin; gamma-Aminobutyric Acid; | 2007 |
Experimental autoimmune prostatitis induces chronic pelvic pain.
Topics: Amines; Analgesics; Anesthetics, Local; Animals; Autoimmune Diseases; Chronic Disease; Cyclohexaneca | 2008 |
Cerebellar cognitive affective syndrome associated with topiramate.
Topics: Amines; Anticonvulsants; Carbamazepine; Cerebellar Diseases; Cerebellum; Cognition Disorders; Cycloh | 2008 |
Exacerbation of seizures in Lennox-Gastaut syndrome by gabapentin.
Topics: Acetates; Adolescent; Amines; Anticonvulsants; Cyclohexanecarboxylic Acids; Epilepsy; Gabapentin; ga | 1996 |
A case of myokymia-cramp syndrome successfully treated with gabapentin.
Topics: Acetates; Amines; Cyclohexanecarboxylic Acids; Extremities; Fasciculation; Gabapentin; gamma-Aminobu | 1998 |
SUNCT syndrome responsive to gabapentin (Neurontin).
Topics: Acetates; Amines; Analgesics; Conjunctival Diseases; Cyclohexanecarboxylic Acids; Gabapentin; gamma- | 2000 |
Malignant appearing cachexia in an older patient with Bruns-Garland syndrome.
Topics: Acetates; Aged; Amines; Analgesics; Cachexia; Cyclohexanecarboxylic Acids; Diabetes Mellitus, Type 2 | 2000 |
Charles Bonnet's syndrome: complete remission of complex visual hallucinations treated by gabapentin.
Topics: Acetates; Aged; Aged, 80 and over; Amines; Cyclohexanecarboxylic Acids; Female; Gabapentin; gamma-Am | 2001 |